ACRS

Aclaris Therapeutics Inc.

Price

$4.38

return (12m)

135.22%

p/e

-8.25

p/bv

5.01

DIVIDEND YIELD

0.00%

ACRS price

Aclaris Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ACRS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-27.75%

3 months

-21.38%

1 year

135.22%

2 years

267.65%

5 years

-74.50%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals ACRS

Valuation

P/E

-8.25

Sector 1.27

Industry 8.57

P/BV

5.01

Sector 1.88

Industry 3.63

P/Revenue (PSR)

75.98

Sector 1.56

Industry 3.09

EV/EBITDA

-22.36

Sector -46.85

Industry -17.98

EV/EBIT

-22.26

Sector -51.35

Industry -94.21

P/EBITDA

-7.34

Sector -31.66

Industry 7.07

P/EBIT

-7.30

Sector -43.19

Industry -32.11

P/Total Assets

3.48

Sector 0.87

Industry 1.32

P/Net Current Assets

14.64

Sector -26.04

Industry -3.44

P/Working Capital

8.98

Sector -4.00

Industry 7.65

EPS

-0.53

Sector -0.70

Industry -0.23

BVPS

0.87

Sector 4.48

Industry 8.61

Efficiency

Gross Margin

79.52%

Sector 49.44%

Industry 55.16%

EBITDA Margin

-1,462.92%

Sector -282.02%

Industry -13.47%

EBIT Margin

-1,469.49%

Sector -164.03%

Industry -25.89%

Operating Margin

-100.00%

Sector -19.60%

Industry -5.67%

Net Profit Margins

-100.00%

Sector -23.82%

Industry -7.67%

Asset Turnover

0.01

Sector 0.13

Industry 0.13

Profitability

ROE

-60.79%

Sector -23.80%

Industry -24.00%

ROA

-42.15%

Sector -24.22%

Industry -5.96%

ROIC

-101.41%

Sector -587.47%

Industry -21.90%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.46

Sector 1.90

Industry 2.56

Net Debt / EBITDA

3.84

Sector -23.34

Industry 9.41

Net Debt / EBIT

3.82

Sector -11.26

Industry -2.82

Net Debt / Equity

-0.73

Sector -0.63

Industry -0.19

Gross Debt / Equity

0.00

Sector -0.73

Industry 0.42

Equity/Assets

0.69

Sector 0.46

Industry 0.50

Liabilities/Assets

0.31

Sector 0.50

Industry 0.53

Growth

5Y Revenue CAGR

3.98%

Sector -

Industry -

5Y Earnings CAGR

-3.58%

Sector -

Industry -

Fundamentals ACRS

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ACRS Aclaris Therapeutics Inc.	$4.38	133.96%	0.00%	-8.25	5.01	-60.79%	-100.00%
LLY Eli Lilly and Compay	$1,139.27	38.90%	0.59%	38.06	30.01	78.84%	33.53%
SNY Sanofi	$39.70	-17.07%	4.45%	3.72	0.69	18.43%	14.25%
GSK GlaxoSmithKline PLC	$46.95	7.91%	3.77%	14.44	4.08	28.24%	14.54%
CRMD CorMedix Inc.	$7.23	-34.62%	0.00%	3.03	1.23	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$25.11	-6.98%	0.00%	13.95	1.43	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$12.16	-13.79%	0.69%	27.58	2.49	9.03%	10.14%
ENLV Enlivex Therapeutics Ltd.	$0.40	-97.41%	0.00%	0.01	0.00	63.85%	0.00%
JNJ Johnson & Johnson	$255.81	40.61%	2.06%	29.27	7.25	24.76%	21.48%
ISRG Intuitive Surgical Inc.	$395.40	-9.73%	0.00%	44.62	7.65	17.15%	28.44%
NVS Novartis AG	$140.03	8.37%	2.22%	20.91	6.36	30.41%	23.29%
TMO Thermo Fisher Scientific Inc.	$652.02	23.39%	0.28%	34.69	4.59	13.22%	15.04%
ABT Abbott Laboratories	$96.56	-25.26%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$86.94	-4.56%	3.30%	21.10	2.17	10.29%	13.93%
CVS CVS Health Corporation	$86.67	17.21%	3.09%	22.49	1.38	6.12%	1.18%
BSX Boston Scientific Corp.	$42.80	-55.35%	0.00%	17.31	2.55	14.73%	17.49%
TMDX TransMedics Group Inc.	$77.58	-32.47%	0.00%	17.68	5.18	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$520.16	-16.12%	0.00%	36.04	25.47	70.67%	25.03%
RMD ResMed Inc.	$220.18	-17.85%	1.12%	20.92	4.84	23.13%	26.94%
HCA HCA Healthcare Inc.	$428.58	1.07%	0.71%	13.82	-29.45	-213.15%	8.77%
COHR Coherent Inc.	$336.58	193.57%	0.00%	81.57	5.84	7.16%	11.31%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ACRS - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Aclaris Therapeutics

Aclaris Therapeutics Inc.

Average Investor10 user rating

4.0 (1 people)

United States

14 years

Founded: 2012

2015

Time since IPO - 11 years

78

Employees

Aclaris Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $624.47 million, with shareholders equity totaling $124.58 million.

The company employs approximately 78 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Aclaris Therapeutics Inc. reported $8.22 million in revenue, generating net income of $-75.74 million.

Key financial metrics include a P/E ratio of -8.25, a price-to-book (P/B) ratio of 5.01, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ACRS.

Market cap

$624.47 million

Net worth

$124.58 million

$124,581,000.00

Assets

$179.69 million

$179,693,000.00

Total Shares Outstanding

142.74 million

142,736,000

Average Daily Trading Volume

$2.41 million

$2,412,210.68

Sector

Health

Industry

Pharmaceutical Products

ACRS

ACRS revenue and profits

Financial Results ACRS

DRAG THE FRAME TO SEE MORE DATA

ACRS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$86.67 15,38% (12M)

P/E

22.49

3.09%

ROE

6.12%

P/BV

1.38

CI - Cigna

$267.68 --11,99% (12M)

P/E

10.33

2.31%

ROE

16.04%

P/BV

1.66

CNC - Centene

$62.50 61,49% (12M)

P/E

-6.05

0.00%

ROE

-22.53%

P/BV

1.36

HUM - Humana

$383.17 37,00% (12M)

P/E

35.89

0.93%

ROE

6.63%

P/BV

2.38

SNY - Sanofi

$39.70 --18,93% (12M)

P/E

3.72

4.45%

ROE

18.43%

P/BV

0.69

JNJ - Johnson & Johnson

$255.81 38,68% (12M)

P/E

29.27

2.06%

ROE

24.76%

P/BV

7.25

LLY - Eli Lilly

$1,139.27 36,51% (12M)

P/E

38.06

0.59%

ROE

78.84%

P/BV

30.01

HCA - HCA Healthcare

$428.58 0,25% (12M)

P/E

13.82

0.71%

ROE

-213.15%

P/BV

-29.45